Trial intelligence / Profile preview

CCCG-ALL-2008 Protocol for Childhood ALL

NCT00707083Phase 3Completed

Sponsor
Prince of Wales Hospital
Start
May 2008
Primary completion
Oct 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of mercaptopurine, methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Prince of Wales Hospital. Started May 2008; status: completed.

02

Drugs

mercaptopurinemethotrexate
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00707083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00707083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call